Deep learning is one of the subsets of machine learning that is widely used in artificial intelligence (AI) field such as natural language processing and machine vision. The deep convolution neural network (DCNN) extracts high-level concepts from low-level features and it is appropriate for large volumes of data. In fact, in deep learning, the high-level concepts are defined by low-level features. Previously, in optimization algorithms, the accuracy achieved for network training was less and high-cost function. In this regard, in this study, AdaptAhead optimization algorithm was developed for learning DCNN with robust architecture in relation to the high volume data. The proposed optimization algorithm was validated in multi-modality MR images of BRATS 2015 and BRATS 2016 data sets. Comparison of the proposed optimization algorithm with other commonly used methods represents the improvement of the performance of the proposed optimization algorithm on the relatively large dataset. Using the Dice similarity metric, we report accuracy results on the BRATS 2015 and BRATS 2016 brain tumor segmentation challenge dataset. Results showed that our proposed algorithm is significantly more accurate than other methods as a result of its deep and hierarchical extraction.
Image segmentation is one of the most common steps in digital image processing, classifying a digital image into different segments. The main goal of this paper is to segment brain tumors in magnetic resonance images (MRI) using deep learning. Tumors having different shapes, sizes, brightness and textures can appear anywhere in the brain. These complexities are the reasons to choose a high-capacity Deep Convolutional Neural Network (DCNN) containing more than one layer. The proposed DCNN contains two parts: architecture and learning algorithms. The architecture and the learning algorithms are used to design a network model and to optimize parameters for the network training phase, respectively. The architecture contains five convolutional layers, all using 3 × 3 kernels, and one fully connected layer. Due to the advantage of using small kernels with fold, it allows making the effect of larger kernels with smaller number of parameters and fewer computations. Using the Dice Similarity Coefficient metric, we report accuracy results on the BRATS 2016, brain tumor segmentation challenge dataset, for the complete, core, and enhancing regions as 0.90, 0.85, and 0.84 respectively. The learning algorithm includes the task-level parallelism. All the pixels of an MR image are classified using a patch-based approach for segmentation. We attain a good performance and the experimental results show that the proposed DCNN increases the segmentation accuracy compared to previous techniques.
Multiple sclerosis (MS) is a degenerative disease of the covering around the nerves in the central nervous system. It damages the immune cells and causes small lesions in the patient's brain. Automated image recognition techniques can be employed for increasing the accuracy of detection. The use of convolutional neural networks (CNN) is the most common deep learning method for detecting lesions in image. Due to the specific features of MS lesions, the use of spectral features especially multiresolution enables the highlighting of images lesions and leads to a more accurate diagnosis. In the present study, the Haar wavelet transform was applied to make use of the spectral information. The proposed method is a combination of the two‐dimensional discrete Haar wavelet transform and the CNN network. Experiments on the image data of 38 patients and 20 healthy individuals revealed accuracy, precision, and sensitivity of 99.05%, 98.43%, and 99.14%, respectively.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.